Pradaxa Drug Interactions
Currently displaying 111 drugs known to have a major interaction with Pradaxa (dabigatran).
- 111 major drug interactions
- 170 moderate drug interactions
- 9 minor drug interactions
Major interactions with Pradaxa (dabigatran)
Note: Showing generic names only.
A
- abciximab
- acalabrutinib
- adagrasib
- ado-trastuzumab emtansine
- aducanumab
- alteplase
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
B
C
D
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- desirudin
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- dicumarol
- diflunisal
- dipyridamole
- donanemab
- dronedarone
- drotrecogin alfa
E
F
H
I
- ibritumomab
- ibrutinib
- ibuprofen
- indomethacin
- inotersen
- iodine i 131 tositumomab
- ipilimumab
- itraconazole
K
L
M
N
O
P
- panobinostat
- phenobarbital
- phenylbutazone
- phenytoin
- piroxicam
- plasminogen, human
- ponatinib
- prasugrel
- primidone
R
S
T
- temsirolimus
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- tranexamic acid
U
V
W
Z
Pradaxa disease interactions
There are 4 disease interactions with Pradaxa (dabigatran) which include:
More about Pradaxa (dabigatran)
- Pradaxa consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (95)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: thrombin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.